{
  "id": "phase3_option_a_retatrutide",
  "name": "Phase 3 Option A: Metabolic Intensification (Retatrutide)",
  "peptides": [
    "retatrutide"
  ],
  "primary_goals": [
    "Aggressive weight/fat loss",
    "Maximum metabolic impact",
    "Beta cell support",
    "Insulin sensitivity"
  ],
  "mechanism": "Triple agonist (GLP-1/GIP/Glucagon) provides comprehensive metabolic regulation. GLP-1 for appetite/insulin, GIP for adipose remodeling, Glucagon for energy expenditure and hepatic fat oxidation",
  "protocol": {
    "retatrutide": {
      "dose": "Start 1-2mg, titrate to 8-12mg weekly",
      "frequency": "Once weekly",
      "administration": "Subcutaneous",
      "titration": "Increase by 2mg every 4 weeks based on tolerance",
      "timing": "Consistent weekly schedule"
    }
  },
  "phase": "Phase 3 - Optional",
  "duration": "If aggressive metabolic intervention needed",
  "cycling": "Per medical protocol, typically continuous while losing weight",
  "cost_estimate": "$200-350/month",
  "synergy_notes": "Nuclear option for metabolic health. Add only if Phase 1-2 insufficient for visceral fat/insulin goals",
  "considerations": [
    "Requires slow titration",
    "Monitor for GI side effects",
    "Most powerful option for beta cell support",
    "Typically requires medical supervision",
    "Consider if Phases 1-2 don't achieve metabolic goals"
  ],
  "ordered": true,
  "stack_status": "All peptides ordered",
  "conversation_tier": "Phase 3 Option A - Aggressive Metabolic"
}